📣 VC round data is live. Check it out!
- Public Comps
- Lifeward
Lifeward Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lifeward and similar public comparables like Icecure Medical, Co-Diagnostics, Geratherm Medical, Iridex and more.
Lifeward Overview
About Lifeward
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
Founded
2001
HQ

Employees
80
Website
Financials (LTM)
EV
$17M
Valuation Multiples
Start free trialLifeward Financials
Lifeward reported last 12-month revenue of $25M.
In the same LTM period, Lifeward generated $10M in gross profit and had net loss of ($20M).
Revenue (LTM)
Lifeward P&L
In the most recent fiscal year, Lifeward reported revenue of $22M and EBITDA of ($17M).
Lifeward is unprofitable as of last fiscal year, with gross margin of 38%, EBITDA margin of (75%), and net margin of (90%).
Financial data powered by Morningstar, Inc.
Lifeward Stock Performance
Lifeward has current market cap of $19M, and enterprise value of $17M.
Market Cap Evolution
Lifeward's stock price is $6.97.
Lifeward share price decreased by 3.9% in the last 30 days, and by 52.8% in the last year.
Lifeward has an EPS (earnings per share) of $-7.17.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $17M | $19M | 0.0% | -3.9% | -5.8% | -52.8% | $-7.17 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLifeward Valuation Multiples
Lifeward trades at 0.7x EV/Revenue multiple, and (1.0x) EV/EBITDA.
EV / Revenue (LTM)
Lifeward Financial Valuation Multiples
As of May 26, 2026, Lifeward has market cap of $19M and EV of $17M.
Lifeward has a P/E ratio of (1.0x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lifeward Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Lifeward Margins & Growth Rates
Lifeward grew revenue by 34% but net profit decreased by 2% in the last fiscal year.
In the most recent fiscal year, Lifeward reported gross margin of 38%, EBITDA margin of (75%), and net margin of (90%).
Lifeward Margins
Lifeward Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Lifeward Operational KPIs
Lifeward's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.3M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Lifeward Competitors
Lifeward competitors include Icecure Medical, Co-Diagnostics, Geratherm Medical, Iridex, Elbit Imaging, Cambridge Cognition, Promimic, Scandinavian Real Heart, Inspira Technologies and Integrum.
Most Lifeward public comparables operate across Medical Devices, HealthTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.3x | 2.4x | (0.8x) | — | |||
| 19.9x | 19.9x | (0.4x) | — | |||
| 0.4x | — | 2.7x | — | |||
| 0.4x | 0.4x | 9.5x | 14.0x | |||
| — | — | — | — | |||
| 1.7x | 1.5x | (31.1x) | (88.9x) | |||
| 4.1x | — | (92.3x) | — | |||
| — | — | (4.1x) | — | |||
This data is available for Pro users. Sign up to see all Lifeward competitors and their valuation data. Start Free Trial | ||||||
Lifeward Funding History
Before going public, Lifeward raised $18M in total equity funding, across 2 rounds.
Lifeward Funding Rounds
Lifeward M&A Activity
Lifeward has acquired 2 companies to date.
Last acquisition by Lifeward was on March 25th 2026. Lifeward acquired OraTech Pharmaceuticals for $47M (EV/Revenue multiple of ).
Latest Acquisitions by Lifeward
| Description | OraTech Pharmaceuticals develops and commercializes Protein Oral Delivery (POD™) technology to convert injectable protein medications into oral capsules by protecting them from gastric acid and improving intestinal absorption. | AlterG is a Fremont-headquartered developer of differential air pressure technology featured in the Anti-Gravity Treadmill for physical therapy and athletic training. The system enables precise body weight reduction during gait and mobility exercises, supporting rehabilitation in clinics, sports facilities, and performance centers worldwide. |
| HQ Country | — | |
| HQ City | — | San Francisco, CA |
| Deal Date | 25 Mar 2026 | 8 Aug 2023 |
| Valuation | $47M | $19M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Lifeward acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lifeward
| When was Lifeward founded? | Lifeward was founded in 2001. |
| Where is Lifeward headquartered? | Lifeward is headquartered in United States. |
| How many employees does Lifeward have? | As of today, Lifeward has over 80 employees. |
| Who is the CEO of Lifeward? | Lifeward's CEO is William Mark Grant. |
| Is Lifeward publicly listed? | Yes, Lifeward is a public company listed on Nasdaq. |
| What is the stock symbol of Lifeward? | Lifeward trades under LFWD ticker. |
| When did Lifeward go public? | Lifeward went public in 2014. |
| Who are competitors of Lifeward? | Lifeward main competitors include Icecure Medical, Co-Diagnostics, Geratherm Medical, Iridex, Elbit Imaging, Cambridge Cognition, Promimic, Scandinavian Real Heart, Inspira Technologies, Integrum. |
| What is the current market cap of Lifeward? | Lifeward's current market cap is $19M. |
| What is the current revenue of Lifeward? | Lifeward's last 12 months revenue is $25M. |
| What is the current revenue growth of Lifeward? | Lifeward revenue growth (NTM/LTM) is 54%. |
| What is the current EV/Revenue multiple of Lifeward? | Current revenue multiple of Lifeward is 0.7x. |
| Is Lifeward profitable? | No, Lifeward is not profitable. |
| What is the current net income of Lifeward? | Lifeward's last 12 months net income is ($20M). |
| How many companies Lifeward has acquired to date? | As of May 2026, Lifeward has acquired 2 companies. |
| What was the largest acquisition by Lifeward? | $47M acquisition of OraTech Pharmaceuticals on 25th March 2026 was the largest M&A Lifeward has done to date. |
| What companies Lifeward acquired? | Lifeward acquired OraTech Pharmaceuticals and AlterG. |
| In how many companies Lifeward has invested to date? | Lifeward hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Lifeward
Lists including Lifeward
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
